Hepatitis B e Antigen-Negative Single Hepatocyte Analysis Shows Transcriptional Silencing and Slow Decay of Infected Cells With Treatment
- Johns Hopkins Univ., Baltimore, MD (United States). School of Medicine
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Johns Hopkins Univ., Baltimore, MD (United States)
- Virginia Commonwealth Univ., Richmond, VA (United States)
- Joint Pathology Center (JPC), Silver Spring, MD (United States)
Background Nucleos(t)ide analogues (NUCs) rarely cure chronic hepatitis B (CHB) because they do not eliminate covalently closed circular deoxyribonucleic acid, the stable replication template. In hepatitis B e antigen (HBeAg)-positive CHB during NUCs, HBV-infected cells decline slowly and are transcriptionally silenced. Whether these occur in HBeAg-negative CHB is unknown. Methods Using paired liver biopsies separated by 2.7–3.7 years in 4 males with HIV and HBeAg-negative CHB at both biopsies and 1 male with HIV who underwent HBeAg seroconversion between biopsies, we quantified amounts of viral nucleic acids in hundreds of individual hepatocytes. Results In the 4 persistently HBeAg-negative participants, HBV-infected hepatocytes ranged from 6.2% to 17.7% (biopsy 1) and significantly declined in 3 of 4 by biopsy 2. In the HBeAg seroconverter, the proportion was 97.4% (biopsy 1) and declined to 81.9% at biopsy 2 (P < .05). Here, we extrapolated that HBV eradication with NUCs would take >100 years. At biopsy 1 in the persistently HBeAg-negative participants, 23%–56.8% of infected hepatocytes were transcriptionally inactive—higher than we observed in HBeAg-positive CHB—and significantly declined in 1 of 4 at biopsy 2. Conclusions In HBeAg-negative CHB on NUCs, the negligible decline in infected hepatocytes is similar to HBeAg-positive CHB, supporting the need for more potent therapeutics to achieve functional cure.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA)
- Grant/Contract Number:
- 89233218CNA000001
- OSTI ID:
- 2367489
- Report Number(s):
- LA-UR--22-32178
- Journal Information:
- Journal of Infectious Diseases, Journal Name: Journal of Infectious Diseases Journal Issue: 9 Vol. 228; ISSN 0022-1899
- Publisher:
- Infectious Diseases Society of AmericaCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment
A multiscale model of the action of a capsid assembly modulator for the treatment of chronic hepatitis B